What is Synjardy used for?
Synjardy (empagliflozin/metformin) is prescribed to improve blood sugar control in adults with type 2 diabetes. It’s used along with diet and exercise, and it may be chosen for its benefits on glucose levels when metformin and an SGLT2 inhibitor are appropriate.
How does Synjardy work for type 2 diabetes?
Synjardy combines two medicines with different mechanisms:
- Metformin lowers glucose production in the liver and improves insulin sensitivity.
- Empagliflozin helps the kidneys remove extra glucose from the bloodstream through urine (an SGLT2 inhibitor effect).
Is Synjardy used for heart or kidney outcomes too?
Some SGLT2 inhibitors are also used to reduce risk of certain cardiovascular or kidney events in specific patient groups with type 2 diabetes. If you tell me your situation (for example, whether you have known heart disease or chronic kidney disease), I can narrow down the specific “used for” indications.
Who typically isn’t a good candidate for Synjardy?
Synjardy is generally for type 2 diabetes in adults, and it is not the typical choice for type 1 diabetes. It also may not be appropriate for some people depending on kidney function and other clinical factors.
What are common reasons people ask about Synjardy’s use?
People often search “Synjardy used for” to confirm:
- whether it’s meant to replace metformin alone,
- whether it’s for diabetes only or also for heart/kidney protection,
- and whether it’s appropriate for adults with type 2 diabetes.
If you share the exact wording on your prescription label (or your age and whether you have heart failure, prior heart attack/stroke, or kidney disease), I can align the answer to the likely intended use.